In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis

Brain

Volumn 122, Issue 10, 1999, Pages 1933-1939

  De Stefano, Nicola ^b   Narayanan, Sridar ^b   Matthews, Paul M ^b   Francis, Gordon S ^b   Antel, Jack P ^b   Arnold, Douglas L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

Axon; Demyelination; Magnetic resonance spectroscopy; Multiple sclerosis; N acetyl aspartate

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ARTICLE; DEMYELINATION; HEMISPHERE; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE INJURY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ACUTE DISEASE; ADULT; ASPARTIC ACID; AXONS; BRAIN; CREATINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEURAL PATHWAYS; PROTONS; TIME FACTORS;

EID: 0032852674     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.10.1933     Document Type: Article

References (41)

1. Arnold DL, Matthews PM. Practical aspects of clinical applications of MRS in the brain. In: Young IR, Charles HC, editors. MR spectroscopy: clinical applications and techniques. London: Martin Dunitz; 1996. p. 139-59.
2. Arnold DL, Matthews PM, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med 1990; 14: 154-9.
3. Baron JC. Positron tomography in cerebral ischemia. A review. Neuroradiology 1985; 27: 509-16.
4. Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. [Review]. Neurosci Biobehav Rev 1989; 13: 23-31.
5. Bowler JV, Wade JP, Jones BE, Nijran K, Jewkes RF, Cuming R, et al. Contribution of diaschisis to the clinical deficit in human cerebral infarction. Stroke 1995; 26: 1000-6.
6. Cao Y, D'Olhaberriague L, Vikingstad EM, Levine SR, Welch KM. Pilot study of functional MRI to assess cerebral activation of motor function after poststroke hemiparesis. Stroke 1998; 29: 112-22.
7. Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117: 49-58.
8. Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss [published erratum appears in Brain 1996; 119: 1415]. Brain 1995: 118, 1583-92.
9. Davies SE, Newcombe J, Williams SR, McDonald WI, Clark JB. High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochem 1995; 64: 742-8.
10. De Stefano N, Matthews PM, Antel JP, Preul M, Francis G, Arnold DL. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995a; 38: 901-9.
11. De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995b; 34: 721-7.
12. De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998; 121: 1469-77.
13. 1H NMR spectroscopic imaging [abstract]. Proc Soc Magn Reson Med 1991; 1: 472.
14. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-9.
15. Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, Francis GS, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 1998; 121: 103-13.
16. Fulham MJ, Dietz MJ, Duyn JH, Shih HH, Alger JR, Di Chiro G. Transsynaptic reduction in N-acetyl-aspartate in cerebellar diaschisis: a proton MR spectroscopic imaging study. J Comp Assist Tomogr 1994; 18: 697-704.
17. Grossman RI, Lenkinski RE, Ramer KN, Gonzalez-Scarano F, Cohen JA. MR proton spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 1992; 13: 1535-43.
18. + current. Brain 1996; 119: 457-63.
19. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
20. Lumsden CE. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology, Vol. 9. Amsterdam: North-Holland; 1970. p. 296-8.
21. Luyten PR, Groen JP, Vermeulen JW, den Hollander JA. Experimental approaches to image localized human 31P NMR spectroscopy. Magn Reson Med 1989; 11: 1-21.
22. Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis [published erratum appears in Neurology 1991; 41: 1828]. Neurology 1991; 41: 1251-6.
23. Matthews PM, Cianfaglia L, McLaurin J, Cashman N, Sherwin A, Arnold DL, et al. Demonstration of reversible decreases in N-acetylaspartate (NAA) in a neuronal cell line: NAA decreases as a marker of sublethal neuronal dysfunction [abstract]. Proc Int Soc Magn Reson Med 1995; 1: 147.
24. Matthews PM, De Stefano N, Narayanan S, Francis GS, Wolinsky JS, Antel JP, et al. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol 1998; 18: 327-36.
25. Miller DH, Austin SJ, Connelly A, Youl BD, Gadian DG, McDonald WI. Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis [letter] [see comments]. Lancet 1991; 337: 58-9. Comment on: Lancet 1991; 337: 362.
26. Miller DH, Austin SJ, Connelly A, Youl BD, Gadian DG, McDonald WI. Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis [letter] [see comments]. Lancet 1991; 337: 58-9. Comment on: Lancet 1991; 337: 362.
27. Moffett JR, Namboodiri MAA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991; 2: 131-4.
28. Moreau T, Coles A., Wing M, Isaacs J, Hale G, Waldmann H, et al. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 1996; 119: 225-37.
29. Moumdjian RA, Antel JP, Yong VW. Origin of contralateral reactive gliosis in surgically injured rat cerebral cortex. Brain Res 1991; 547: 223-8.
30. Narayanan S, Fu L, Pioro E, De Stefano N, Collins DL, Francis GS, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997; 41: 385-91.
31. Netz J, Lammers T, Homberg V. Reorganization of motor output in the non-affected hemisphere after stroke. Brain 1997; 120: 1579-86.
32. Nieuwenhuys R. Long association and commissural connections. In: Nieuwenhuys R, Voogd J, van Huijzen C, editors. The human central nervous system: a synopsis and atlas. 2nd ed. Berlin: Springer-Verlag 1981. p. 216-7.
33. Pike GB, De Stefano N, Narayanan S, Francis GS, Antel JP, Arnold DL. Longitudinal study of magnetization transfer in multiple sclerosis [abstract]. Proc Int Soc Magn Reson Med 1998; 1: 122.
34. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES. Multiple sclerosis. Pathology of recurrent lesions. Brain 1993; 116: 681-93.
35. Rango M, Spagnoli D, Tomei G, Bamonti F, Scarlato G, Zetta L. Central nervous system trans-synaptic effects of acute axonal injury; a 1H magnetic resonance spectroscopy study. Magn Reson Med 1995; 33: 595-600.
36. Roth K, Kimber BJ, Feeney J. Data shift accumulation and alternate delay accumulation techniques for overcoming dynamic range problems. J Magn Reson 1980; 41: 302.
37. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991; 45: 37-45.
38. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transaction in the lesions of multiple sclerosis [see comments]. New Engl J Med 1998; 338: 278-85. Comment in: New Engl J Med 1998; 338: 323-5.
39. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transaction in the lesions of multiple sclerosis [see comments]. New Engl J Med 1998; 338: 278-85. Comment in: New Engl J Med 1998; 338: 323-5.
40. Wolinsky JS, Narayana PA, Fenstermacher MJ. Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology 1990; 40: 1764-9.
41. Zagzag D, Miller DC, Kleinman GM, Abati A, Donnenfeld H, Budzilovich GN. Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis. Am J Surg Pathol 1993; 17: 537-45.